Mar 04th 2013 - Edison Investment Research today published a report on Surgical Innovations (SUN.L, LSE:SUN, LON:SUN) entitled "Sharpening The Profile". In summary, the report says:
Strong underlying growth in sales of Surgical Innovations’ (SI) branded minimally invasive surgical (MIS) products indicates that its strategy is taking shape. The current capacity squeeze is due partly to the unpredictability of third-party OEM orders. SI will invest c £10m, including a £5m Regional Growth Fund grant, to build a new state-of-the-art plant. It is also investing in the product pipeline, branching into high-growth therapeutic areas in response to the dynamic MIS market.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »